Flexogenix Revenue and Competitors
Estimated Revenue & Valuation
- Flexogenix's estimated annual revenue is currently $5.1M per year.
- Flexogenix's estimated revenue per employee is $189,000
Employee Data
- Flexogenix has 27 Employees.
- Flexogenix grew their employee count by -18% last year.
Flexogenix's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, CEO/CFO | Reveal Email/Phone |
2 | Human Resources Officer | Reveal Email/Phone |
3 | Human Resources Manager | Reveal Email/Phone |
4 | President | Reveal Email/Phone |
5 | General Accountant | Reveal Email/Phone |
6 | Patient Care Representative Supervisor | Reveal Email/Phone |
7 | Clinical Informatics Specialist | Reveal Email/Phone |
8 | Physician Assistant | Reveal Email/Phone |
9 | Medical Group Administrator | Reveal Email/Phone |
Flexogenix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.3M | 14 | -18% | N/A | N/A |
#2 | $17.7M | 73 | 26% | N/A | N/A |
#3 | $5.3M | 28 | 0% | N/A | N/A |
#4 | $5.5M | 29 | -19% | N/A | N/A |
#5 | $5.3M | 28 | 4% | N/A | N/A |
#6 | $22.1M | 82 | 1% | N/A | N/A |
#7 | $101.6M | 301 | 4% | N/A | N/A |
#8 | $4.5M | 24 | -4% | N/A | N/A |
#9 | $0.4M | 3 | 0% | N/A | N/A |
#10 | $0.4M | 3 | -50% | N/A | N/A |
What Is Flexogenix?
For millions of patients experiencing joint pain, facing the prospect of joint replacement surgery along with all of the associated risks and potential unwanted side effects, Flexogenix provides a cost-effective nonsurgical alternative with little to no post-procedural downtime, with most patients able to resume normal activity the same day of the procedure. Treatments are physician administered, FDA approved and, in most cases, completely covered by medical insurance. We custom tailor treatment to each person’s individual needs. Flexogenix offers a no-obligation consultation. If you are a candidate, a medical evaluation will follow and you will receive a detailed treatment plan capitalizing on the latest medical technology focusing on joint viscosupplementation and regenerative therapy, helping to reduce degenerative deterioration and musculoskeletal pain without dangerous side effects or undergoing surgery. At Flexogenix, we share your view that surgery should and can be a last resort. Our professionally trained medical staff will guide you through the entire process. An accurate diagnosis provided by a board certified physician, coupled with a multidisciplinary approach, maximizes the success rate of therapy.
keywords:N/AN/A
Total Funding
27
Number of Employees
$5.1M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 27 | -29% | N/A |
#2 | $6.2M | 27 | -7% | N/A |
#3 | $3.1M | 27 | 13% | N/A |
#4 | $2.7M | 27 | N/A | N/A |
#5 | $4.2M | 27 | 4% | N/A |